We are pleased to announce our appointment by life sciences technology company, TMRW Life Sciences (TMRW).
Since the birth of the first IVF baby over 40 years ago, reproductive medicine has progressed with numerous breakthroughs and discoveries, but the management of frozen specimens has not seen the same level of advancement. Current methods are manual, analog, and labour-intensive, challenged to keep up with increasing levels of demand for fertility services. To help bring IVF care into the 21st Century, TMRW has created the world’s first and only automated, software-guided specimen management platform for the safe and sophisticated management of the precious frozen eggs and embryos that are central to most IVF procedures.
Following a successful launch and setting a new standard of care for eggs and embryos in the United States, TMRW’s ground-breaking technology will soon be available in the UK, with plans to expand into further European regions following this. Our expert Healthcare department will lead the UK PR launch for TMRW, raising awareness of the company’s high-tech software to both consumers and fertility clinics, through a targeted 12-month campaign.
Following a competitive pitch, TMRW appointed PHA to be its chosen agency partner due to our successful track record of working with brands and organisations within the healthcare and fertility sector, as well as our ability to offer an integrated campaign with experts all under one roof.
Fernanda Garcia, UK Marketing Director of TMRW, said; “Up until today, UK fertility clinics have employed the same manual storage methods that were developed more than 40 years ago – so we are excited to be launching the UK’s first and only automated platform for safely storing eggs and embryos into the UK this Spring. We are delighted to have The PHA Group by our side as we launch our pioneering technology into the UK market and can’t wait to start speaking to consumers and fertility clinics through their integrated campaign efforts.”
Georgia Entrican, Account Director leading the TMRW account at The PHA Group, commented; “We are delighted to be chosen as TMRW’s PR agency partner, helping them to launch their ground-breaking technology to the UK market. TMRW’s technology arrives at a critical moment in the UK, following a post-Covid ‘boom’ in patients undergoing egg freezing and IVF. Tapping into our understanding and experience of the healthcare and fertility sector, our integrated PR and social media campaign will look to highlight how TMRW is transforming out-dated and risk prone IVF processes, whilst helping to bring IVF into the 21st Century.”
